James E. Parisi
CIK 1307171 · CFO & Sr MD Finance & Corp Dev · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CME price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
115 PERIMETER CENTER PLACE, SUITE 700
ATLANTA, GA 30346
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CBOE | Director | 9,969 | $335.53 | $3.34M | $0 | 9 | 2026-05-18 |
| ATI Physical Therapy, Inc. (ATIP) Delisted | Director | 7,791 | $0.68 | $5.3K | $50.2K | 2 | 2024-08-22 |
| ATI Physical Therapy, Inc. (ATIP.WS) Delisted | Director | 363,474 | $0.01 | $2.3K | $0 | 6 | 2023-03-27 |
| Cotiviti Holdings, Inc. (COTV) Delisted | Director | 0 | — | — | $162.8K | 8 | 2018-08-27 |
| CME | CFO & Sr MD Finance & Corp Dev | 48,353 | $303.14 | $14.66M | -$3.42M | 21 | 2014-09-17 |
Recent Filings · Page 4 of 5
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-30 | CME | Mixed | −5,000 | -$1.25M | EDGAR |
| 2013-03-19 | CME | Tax (F) | −266 | -$16.8K | EDGAR |
| 2013-03-12 | CME | Grant (A) | +3,320 | $0 | EDGAR |
| 2012-12-11 | CME | Mixed | +2,088 | -$54.9K | EDGAR |
| 2012-09-18 | CME | Grant (A) | +7,428 | $0 | EDGAR |
| 2011-09-19 | CME | Grant (A) | +1,732 | $0 | EDGAR |
| 2011-03-11 | CME | Buy (P) | +670 | $200.8K | EDGAR |
| 2010-09-17 | CME | Grant (A) | +1,472 | $0 | EDGAR |
| 2009-09-17 | CME | Grant (A) | +968 | $0 | EDGAR |
| 2008-07-17 | CME | Exer (M) | +1,000 | $63.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.